Home
How it works
- The Score
- Pre-Check
- Priors
- Pre-Reporting
- Efficiency
- Confidence
- Integration
Clinical Evidence
- Case of the Week
Try MammoScreen
About
- Blog
- Tradeshows
- FAQ
- Contact
Request a Demo

News

Discover the latest News of Mammoscreen® 2D&3D

Sign up for News & Updates

Home
News and Events
News

News

Show all
Company news
Scientific Publications
AI future trends

November 4, 2026

Image-Based Breast Cancer Risk Estimation Across Breast Density and Cancer Invasiveness in Screening Mammography

Image-based breast cancer risk estimation study from MammoScreen by Therapixel

Sign up for News & Updates

SEARCH

CATEGORIES

Company news
Scientific Publications
Case of the week
AI implementation
AI fundamentals
AI exploration & feasibility
AI future trends
AI & radiology daily challenges

RECENT POST

Image-Based Breast Cancer Risk Estimation Across Breast Density and Cancer Invasiveness in Screening Mammography November 4, 2026
Discover what doctors say about AI-assisted mammograms October 30, 2025
RamSoft and Therapixel Announce Commercial Partnership to Deliver Integrated AI-Powered Breast Imaging Solution June 5, 2025
MammoScreen® Breast AI Adopted by Mayo Clinic for Radiology Use May 5, 2025
Therapixel and Onsite Women’s Health Announce Partnership to Deploy MammoScreen® AI for Enhanced Breast Cancer Detection Across National Provider Network April 3, 2025

MammoScreen^® is a product of:

MammoScreen^® is a registered trademark of Therapixel Inc.

Menu

How it Works
Clinical Evidence
Try MammoScreen
About
FAQ
Contact

Extras

Legal info
Privacy Policy
Sitemap

MammoScreen® is 510(k) FDA cleared for FFDM (2D) and DBT (3D).

Contact

1700 W Irving Park Road ST. 209A

Chicago – IL 60613
USA

© 2023 Therapixel | Web design by Domaine-Pack.fr

Privacy Preference Center

Privacy Preferences